These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 34774663)
1. A mathematical model to evaluate the role of memory B and T cells in heterologous secondary dengue infection. Rubio FA; Yang HM J Theor Biol; 2022 Feb; 534():110961. PubMed ID: 34774663 [TBL] [Abstract][Full Text] [Related]
2. A mathematical model to describe antibody-dependent enhancement and assess the effect of limiting cloning for plasma cells in heterologous secondary dengue infection. Alves Rubio F; Mo Yang H Math Med Biol; 2022 Jun; 39(2):169-196. PubMed ID: 35380162 [TBL] [Abstract][Full Text] [Related]
3. A simple mathematical model to describe antibody-dependent enhancement in heterologous secondary infection in dengue. Cerón Gómez M; Yang HM Math Med Biol; 2019 Dec; 36(4):411-438. PubMed ID: 30299478 [TBL] [Abstract][Full Text] [Related]
4. Modeling the Relationship Between Antibody-Dependent Enhancement and Disease Severity in Secondary Dengue Infection. de A Camargo F; Adimy M; Esteva L; Métayer C; Ferreira CP Bull Math Biol; 2021 Jun; 83(8):85. PubMed ID: 34142264 [TBL] [Abstract][Full Text] [Related]
5. Coinfection, Altered Vector Infectivity, and Antibody-Dependent Enhancement: The Dengue-Zika Interplay. Olawoyin O; Kribs C Bull Math Biol; 2020 Jan; 82(1):13. PubMed ID: 31933003 [TBL] [Abstract][Full Text] [Related]
6. Infection severity across scales in multi-strain immuno-epidemiological Dengue model structured by host antibody level. Gulbudak H; Browne CJ J Math Biol; 2020 May; 80(6):1803-1843. PubMed ID: 32157381 [TBL] [Abstract][Full Text] [Related]
7. The role of antibody in enhancing dengue virus infection. Nikin-Beers R; Ciupe SM Math Biosci; 2015 May; 263():83-92. PubMed ID: 25707916 [TBL] [Abstract][Full Text] [Related]
8. Molecular Simulations Reveal the Role of Antibody Fine Specificity and Viral Maturation State on Antibody-Dependent Enhancement of Infection in Dengue Virus. Ripoll DR; Wallqvist A; Chaudhury S Front Cell Infect Microbiol; 2019; 9():200. PubMed ID: 31275864 [TBL] [Abstract][Full Text] [Related]
9. Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients. Chaichana P; Okabayashi T; Puiprom O; Sasayama M; Sasaki T; Yamashita A; Ramasoota P; Kurosu T; Ikuta K PLoS One; 2014; 9(3):e92173. PubMed ID: 24642752 [TBL] [Abstract][Full Text] [Related]
10. Analysis of an asymmetric two-strain dengue model. Kooi BW; Aguiar M; Stollenwerk N Math Biosci; 2014 Feb; 248():128-39. PubMed ID: 24434818 [TBL] [Abstract][Full Text] [Related]
11. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection. Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366 [TBL] [Abstract][Full Text] [Related]
12. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W Front Immunol; 2018; 9():597. PubMed ID: 29740424 [TBL] [Abstract][Full Text] [Related]
14. Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection. Narayan R; Tripathi S Front Cell Infect Microbiol; 2020; 10():580096. PubMed ID: 33123500 [TBL] [Abstract][Full Text] [Related]
15. An epidemiological survey of the current status of Zika and the immune interaction between dengue and Zika infection in Southern Taiwan. Wang WH; Urbina AN; Wu CC; Lin CY; Thitithanyanont A; Assavalapsakul W; Lu PL; Chen YH; Wang SF Int J Infect Dis; 2020 Apr; 93():151-159. PubMed ID: 31982624 [TBL] [Abstract][Full Text] [Related]
16. Why are dengue virus serotypes so distantly related? Enhancement and limiting serotype similarity between dengue virus strains. Kawaguchi I; Sasaki A; Boots M Proc Biol Sci; 2003 Nov; 270(1530):2241-7. PubMed ID: 14613610 [TBL] [Abstract][Full Text] [Related]
17. Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivative. Ayala-Nuñez NV; Jarupathirun P; Kaptein SJ; Neyts J; Smit JM Antiviral Res; 2013 Oct; 100(1):238-45. PubMed ID: 23994499 [TBL] [Abstract][Full Text] [Related]
18. Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus. Renner M; Flanagan A; Dejnirattisai W; Puttikhunt C; Kasinrerk W; Supasa P; Wongwiwat W; Chawansuntati K; Duangchinda T; Cowper A; Midgley CM; Malasit P; Huiskonen JT; Mongkolsapaya J; Screaton GR; Grimes JM Nat Immunol; 2018 Nov; 19(11):1248-1256. PubMed ID: 30323338 [TBL] [Abstract][Full Text] [Related]
19. Replacement of pr gene with Japanese encephalitis virus pr using reverse genetics reduces antibody-dependent enhancement of dengue virus 2 infection. Wang Y; Si L; Luo Y; Guo X; Zhou J; Fang D; Yan H; Zeng G; Jiang L Appl Microbiol Biotechnol; 2015 Nov; 99(22):9685-98. PubMed ID: 26219500 [TBL] [Abstract][Full Text] [Related]
20. Maternal Passive Immunity and Dengue Hemorrhagic Fever in Infants. Adimy M; Mancera PFA; Rodrigues DS; Santos FLP; Ferreira CP Bull Math Biol; 2020 Jan; 82(2):24. PubMed ID: 31993759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]